ArticleClinical epidemiology2020

Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.

Edith M Heintjes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.